Genetics & Metabolism
Alyssa R. Letourneau
Marsha F. Browning
Vivian E. Shih
Inborn Errors of Metabolism
Definition
-
Inherited enzyme mutation alters metabolism → excess or lack of certain metabolites
Incidence
-
1:1400–200,000 live births; NBS screens for many of the disorders
Neonatal Presentation
(Pediatrics 1998;102:E69; Vademecum Metabolicum 2004:3)
-
24–72 hr of life
-
Ill infant w/ nonspecific sx’s: Lethargy, diff feeding, vomiting, abn resp, hypotonia and szr’s
-
Abnormal body or urinary odor
-
MSUD: Urine smells of maple syrup or burnt sugar
-
Isovaleric acidemia and glutaric acidemia type II → pungent, unpleasant “sweaty feet” odor
-
Late Presentation
(Crit Care Clin 2005;21:S9; Vademecum metabolicum 2004:3)
-
>28 d of life; recurrent vomiting, lethargy, or fasting → coma with nonfocal neuro exam
-
Liver dysfxn + mental status changes
Adolescent/Adults Presentation
(J Inherit Metab Dis 2007;30:631)
-
Psychiatric d/o, recurrent rhabdo, myoglobinuria, cardiomyopathy
-
Acute recurring confusion → urea cycle defect, porphyria, homocysteine remethylation defect
-
Chronic psych sx’s → homocystinuria, Wilson dz, adrenoleukodystrophy, some lysosomal d/o
-
Mild mental retardation and personality Δ → homocystinuria, nonketotic hyperglycemia, other.
Specific Triggers of Decompensation
(Vademecum Metabolicum 2004:3)
-
Vomiting, fasting, infection, fever, vaccinations, surgery, accident or injury, changes in diet → protein or carbohydrate metabolism disorders
-
High- protein diet and/or catabolic state → aminoacidopathies, organic acidemia, urea cycle def
-
Fruit, sugar (sucrose), liquid medicines → fructose intolerance
-
Lactose → galactosemia
-
High fat → Fatty acid oxidation disorders
-
Drugs → porphyria, glucose-6-phosphate-dehydrogenase deficiency
-
Extensive exercise → disorders of fatty acid oxidation, glycolysis, respiratory chain
Emergencies
Critical Labs
(Pediatrics 1998;102:E69; Vademecum Metabolicum 2004:4)
-
Stat D-stick, CBC w/diff, chem 7, blood gas, NH3, lactate, plasma and urine amino acids, U/A, urine reducing substances, urine ketones, urine organic acids, ESR
-
CRP, CK, ALT, AST, coagulation studies
-
Store plasma samples for amino acids, acylcarnitine and filter paper (“Guthrie” card)
-
If LP done → freeze CSF for further studies
-
Consider ECG, echo, head imaging
Emergent Treatment
(Pediatrics 1998;102:E69; Vademecum Metabolicum 2004:5)
-
Start Rx before confirmed dx; stop protein, fat, galactose, and fructose intake
-
Consult metabolic specialist
-
1st goal: Remove metabolites (organic acid intermediates or ammonia)
-
Hyperammonia: Immediate HD for coma, vent dependency, or signs of cerebral edema.
-
Urea cycle defects: 6 cc/kg of 10% arginine HCL IV over 90 min.
-
Organic acidemia: Vit B12 (1 mg) IM for B12-responsive form of methylmalonic acidemia. Biotin (10 mg) PO or NGT for biotin-responsive carboxylase deficiency
-
Acidosis: Give bicarb with frequent ABGs; severely acidotic: HD
-
-
2nd goal: Prevent catabolism
-
IV glucose (calories and substitute for nml liver glucose prod) → D10, 150 cc/kg/d w/ lytes
-
Stop protein as above, IV lipids for urea cycle defects
-
-
If unclear diagnosis: Continue glucose drip, review history
-
Follow lytes, glucose, lactate, ABG, keep Na >135 to avoid cerebral edema
-
Ref: www.childrenshospital.org/newenglandconsortium/NBS/Emergency_Protocols.html
-
Metabolic Acidosis and Ketosis
Definition
(Pediatrics 1998;102:E69; Vademecum Metabolicum 2004:11)
-
ABG with anion gap ≥16. Decreased pH, HCO3, Paco2 (if resp compensation)
-
Ketosis present as response to fasting, catabolic state, or ketogenic diet
Presentation
-
Acute metab encephalopathy → lethargy, poor feeding, vomiting, coma, szr’s, ↓ tone, resp distress, or apnea
Ddx
-
Renal bicarb loss → renal Fanconi syndrome, RTA, cystinosis, osteopetrosis → tyrosinemia, fructose intolerance, glycogen storage disease type I, mitochondrial diseases, methylmalonic aciduria (chronic renal damage)
-
GI loss of bicarb → diarrhea
-
↑ organic acids → lactate production or ketosis →infxn, sepsis, ↑ catabolic state, tissue hypoxia, dehydration, intoxication, DKA
Diagnostic Studies and Management
-
Labs as above, Rx according to primary diagnosis
Hypoglycemia
Definition
(Pediatrics 1998;192:E69; Vandemecum Metabolicum 2004:6)
-
Glucose <2.6 mmol/L (45 mg/dL) at all ages
History and Clinical Manifestations
Determine time since last meal, drugs
-
Check hepatomegaly, liver failure signs (palmar erythema, spider angiomata, gynecomastia, jaundice), small genitals, hyperpigmentation, short stature
Ddx
-
Disorders of protein intolerance, carbohydrate metabolism, or fatty acid oxidation
-
Hepatic glycogen storage dz (except Pompe); no glycogenolysis (worse with fasting)
-
In neonate: Need to rule out sepsis, SGA, maternal diabetes; maybe slow adaptation
-
Persistent neonatal hypoglycemia → hyperinsulinemia or hypopituitarism
Labs While Hypoglycemic
-
As above + insulin, cortisol, lactate, free fatty acids, 3-hydroxybutyrate, Ketostix (urine)
-
Acylcarnitine (dried blood spots or plasma); for fatty acid ox disorders + organic acidurias, C-peptide level
-
Spare tube for additional labs
-
Organic acids in the urine
![]() |
Treatment
-
IV glucose at 7–10 mg/kg/min, for calories and to replace normal liver glucose production → D10% glucose, 110–150 cc/kg/d with electrolytes
-
Keep FS >100; If glucose needs >10 mg/kg/min → likely hyperinsulinism
Hyperammonemia
Definition
(Pediatrics 1998;192:E69; Vandemecum Metabolicum 2004:8)
-
Suspect metabolic dz in neonate if NH3 >200 μmol/L; All other ages NH3 >100 μmol/L
Ddx
Always consider medication effect
-
Urea cycle defects (no acidosis) and organic acidemias (+ metabolic acidosis), liver failure
-
Neonates can have transient hyperammonemia of the newborn → sx’s w/in 24 hr of birth; large premature infants with pulm dz. Usually no recurrent hyperammonemia
Labs
Labs as above; must have uncuffed venous or arterial sample, on ice, sent stat
-
AA in plasma and urine, organic acids and orotic acid in urine
-
Acylcarnitine in dried blood spots
Treatment
-
Must contact metabolic team immediately
-
NH3 >500 → central line, art line, HD
-
1st infusion: 12 cc/kg D10 over 2 hr with lytes
-
Arginine hydrochloride 360 mg/kg
-
Na-benzoate 250 mg/kg (alternate pathway for nitrogen excretion)
-
Carnitine 100 mg/kg
-
Ondansetron 0.15 mg/kg IV bolus in noncomatose (to prevent N/V)
-
-
Follow glucose, add insulin if needed, check ammonia after 2 hr
-
Ref: Neonate: www.childrenshospital.org/newenglandconsortium/NBS/neonate2.html
-
Infant/child: www.childrenshospital.org/newenglandconsortium/NBS/infant_child.html
Abnormal Newborn Screen
Newborn Screen
(Vademecum Metabolicum 2004:53)
www.childrenshospital.org/newenglandconsortium/NBS/Emergency_Protocols.html
-
Started in the 1960s for PKU → broadened to many disorders w/ regional variations
Galactosemia
Definition
(Pediatrics 1998;102:E69; Pediatrics 2006;118:E934; Vademecum Metabolicum 2004:3)
-
Lactose is broken down into glucose and galactose for absorption
-
AR deficiency in enzymes → accumulation of glactose-1-phosphate and galactitol
Incidence
-
“Classic galactosemia”: Most common with galactose-1-phosphate uridyltransferase (GALT) deficiency → 1:47,000 newborns
-
Galactokinase (GALK) def → 1:1,000,000; Galactose-4′-epimerase (GALE) def → rare
Presentation
-
Progressive jaundice and liver dysfunction
-
First 2 wk of life → V/D, poor weight gain, cataracts, indirect hyperbili from hemolysis
-
Most states screen for it on NBS:
-
Galactose (total) 20–30 mg/dL; No Rx. Outpatient review
-
Repeat screening of dried blood spot, galactose, GALT activity
-
-
Galactose (total) 30–40 mg/dL; repeat as above
-
Start lactose-free milk, outpt review, follow-up repeat labs
-
-
Galactose (total) >40 mg/dL; hospitalization, lactose-free diet
-
Check liver and kidney function, coagulation and ultrasound
-
Check galactose, galactose-1-phosphate, GALT activity
-
-
Treatment
-
Galactose-free formula
-
If ill: Supportive care, Vit K, FFP, Abx for presumed Gram-negative sepsis and phototherapy for hyperbilirubinemia
-
Usually improve w/ removal of galactose; check all meds after dx (many contain galactose)
Prognosis
-
Persistent liver disease, cataracts, mental retardation
-
Many die of E. coli sepsis
Phenylketonuria/Phenylalaninemia
Definition
(Pediatrics 2006;118:E934; Vademecum Metabolicum 2004:71)
-
Abnormal increase in amino acid phenylalanine in blood
-
Deficiency of liver enzyme phenylalanine hydroxylase → impairs neurotransmitter production
-
If >20 mg/dL with accumulation of phenyl ketones → phenylketonuria (PKU)
-
Can be a benign process
Incidence
-
1:13,500–19,000 for PKU; non-PKU hyperphenylalaninemia 1:48,000
-
AR w/ >400 mutations; if untreated → severe brain damage, MR, seizures, spasticity
Treatment
-
Early Rx important → admit to the hospital, inverse relationship between time to treatment and IQ
-
Positive NBS → check quantitative level of phenylalanine and tyrosine concentration
-
Provide with medical protein sources low in phenylalanine
-
Follow phenylalanine levels and keep low
Management of Known Inborn Errors of Metabolism
Urea Cycle Disorders
Definition
(Vademecum Metabolicum 2004)
-
Inherited enzyme and transport protein def w/ ↓ removal excess NH3 from protein metabolism
Incidence
-
Most common inborn errors of metabolism; 1:8000
-
Usually presents after newborn period, at all ages
Presentation
-
Neonates → lethargy, poor feeding, hyperventilation, seizures, encephalopathy
-
Infants/children → FTT, feeding problems, vomiting, neuro sx’s, lethargy, ataxia, szr’s
-
Teens/adults: Chronic neuro or psych sx’s, behav probs, disorientation, lethargy, psychosis
Diagnosis
-
Based on abnormal plasma and urine amino acid levels
Ornithine Transcarbamylase Deficiency (OTC)
-
Most common; 1:14,000 incidence; X-linked, many w/ residual enzyme activity
-
Can present between 1 mo of age to childhood with significant illness; inc urine orotic acid
Treatment
-
Acute therapy → see previous discussion
-
Long-term management: Metabolic team to assess diet, low protein diets, good fluid intake, vaccinations, and treating infections early.
Aminoacidopathies
Definition
(Vademecum Metabolicum 2004:57)
-
Def of enzymes for AA metab → toxic substances accumulate in brain, liver, and kidneys
-
If known disorder of AA metabolism and ill → call metabolic team
-
Labs as above and emergency Rx glucose as above, stop protein intake, keep Na >140 to prevent cerebral edema, Abx, detox prn w/ diuresis or HD, Vits and carnitine depending on dz
Tyrosinemia
(Am J Med Genet C Semin Med Genet 2006;142C:121: Vademecum Metabolicum 2004:72)
-
Accumulation of tyrosine in fluids and tissue
-
Type I is the most severe → liver failure, neurologic crises, rickets, hepatocarcinoma
Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

